Q&A With Miruna Sasu, president and CEO, COTA, Inc.
April 20, 2022 From exposing disparities in care to guiding better patient outcomes to helping reign in the costs of care, the use of real-world data (RWD) in oncology can...
Author: admin
Real-World Data Show More Research is Needed for Risk Stratification in Advanced Colon Cancer
April 20, 2022 In an interview with Targeted Oncology, Luv Hajirawala, MD, discussed the relevance of high-risk features in patients with stage III colon cancer, and how a recent real-world...
Tonix Pharmaceuticals Announces Results of Retrospective Observational Database Study In Over 50,000 Long COVID Patients
April 20, 2022 07:00 ET | Source: Tonix Pharmaceuticals Holding Corp. Over 40% of Long COVID Patients Had Fibromyalgia-Like Multi-Site Pain Symptoms Rate of Opioid Use in Long COVID Patients with Multi-Site...
Investigating FDA’s breakthrough devices, big data ethics, & AI for colon cancer
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and...
4 Pitfalls To Avoid With RWE For Regulatory Submissions
By Sean Hilscher, vice president, Greenleaf Health The FDA’s release of four draft guidances on real-world evidence (RWE) at the tail end of 2021 is a productive step toward implementing...
Excelra Makes Strategic Investment in Anlitiks, a Disruptive HEOR and RWE Technology-led Consulting Company
HYDERABAD, India and BOSTON, Mass., April 19, 2022 /PRNewswire/ — Excelra, a leading global Data and Analytics provider for Life Science organizations, has announced a strategic majority investment in Anlitiks, a young and rapidly growing...
Real-world evidence of daratumumab monotherapy in relapsed/refractory multiple myeloma patients and efficacy on soft-tissue plasmacytomas
Abstract Daratumumab monotherapy was first investigated in GEN501 and SIRIUS trials in relapsed/refractory multiple myeloma (RRMM) patients, showing positive results. However, there is a lack of information on plasmacytoma response....
Palantir Expands Longstanding CDC Partnership for Disease Monitoring and Response
Centers for Disease Control and Prevention Continues Critical Work to Modernize Data ManagementApril 15, 2022 06:59 AM Eastern Daylight Time DENVER–(BUSINESS WIRE)–Palantir Technologies Inc. (NYSE:PLTR) today announced an extension and...
Palantir to Unveil New Products in Apollo
April 14, 2022 06:59 AM Eastern Daylight Time DENVER–(BUSINESS WIRE)–Palantir Technologies Inc. (NYSE: PLTR) today announced that it will unveil a new suite of products available within the Palantir Apollo...
EVERSANA and UpScriptHealth Announce Integrated, Direct-to-Patient Platform, Transforming the Patient Journey to Accelerate Therapy Access, Affordability and Adherence
CHICAGO and SCOTTSDALE, Ariz., April 14, 2022 /PRNewswire/ — EVERSANA™, the pioneer of next-generation commercial services to the global life sciences industry, and UpScriptHealth™, the leading telehealth and virtual prescribing platform serving life sciences companies, today announced...